186 related articles for article (PubMed ID: 1285336)
1. Mechanisms of evasion of Schistosoma mansoni schistosomula to the lethal activity of complement.
Ramalho-Pinto FJ; Carvalho EM; Horta MF
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():111-6. PubMed ID: 1285336
[TBL] [Abstract][Full Text] [Related]
2. Decay accelerating factor (DAF) as the host antigen with protective activity to complement killing of schistosomula.
Ramalho-Pinto FJ
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():213-6. PubMed ID: 2474124
[TBL] [Abstract][Full Text] [Related]
3. Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro.
Horta MF; Ramalho-Pinto FJ
J Exp Med; 1991 Dec; 174(6):1399-406. PubMed ID: 1720809
[TBL] [Abstract][Full Text] [Related]
4. Binding of GPI-PLD-treated DAF to the surface of Schistosoma mansoni schistosomula.
Carvalho EM; Metz CN; Davitz MA; Ramalho-Pinto FJ
Braz J Med Biol Res; 1994 Feb; 27(2):457-62. PubMed ID: 7521707
[TBL] [Abstract][Full Text] [Related]
5. Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni.
Marikovsky M; Parizade M; Arnon R; Fishelson Z
Eur J Immunol; 1990 Jan; 20(1):221-7. PubMed ID: 2307175
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma mansoni: comparison of the killing effect of granulocytes and complement with or without antibody on fresh and cultured schistosomula in vitro.
Novato-Silva E; Nogueira-Machado JA; Gazzinelli G
Am J Trop Med Hyg; 1980 Nov; 29(6):1263-7. PubMed ID: 7446818
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of phosphatidylinositol-linked membrane proteins on erythrocytes of different subpopulations in paroxysmal nocturnal hemoglobinuria.
Cui Y; Zhang ZN; Liu EK; Pan HZ
Chin Med J (Engl); 1993 May; 106(5):323-30. PubMed ID: 7691484
[TBL] [Abstract][Full Text] [Related]
8. Proteases secreted by transforming schistosomula of Schistosoma mansoni promote resistance to killing by complement.
Marikovsky M; Arnon R; Fishelson Z
J Immunol; 1988 Jul; 141(1):273-8. PubMed ID: 3132503
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the reduced surface antigenicity of developing Schistosoma mansoni schistosomula is due to antigen shedding rather than host molecule acquisition.
Pearce EJ; Basch PF; Sher A
Parasite Immunol; 1986 Jan; 8(1):79-94. PubMed ID: 2421228
[TBL] [Abstract][Full Text] [Related]
10. Subclasses of rat IgG active in the killing of schistosomula of Schistosoma mansoni in vitro and in vivo.
Horta MF; Ramalho-Pinto FJ
J Immunol; 1984 Dec; 133(6):3326-32. PubMed ID: 6491290
[TBL] [Abstract][Full Text] [Related]
11. Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59.
Parizade M; Arnon R; Lachmann PJ; Fishelson Z
J Exp Med; 1994 May; 179(5):1625-36. PubMed ID: 7513011
[TBL] [Abstract][Full Text] [Related]
12. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.
Santoro F; Lachmann PJ; Capron A; Capron M
J Immunol; 1979 Oct; 123(4):1551-7. PubMed ID: 113459
[TBL] [Abstract][Full Text] [Related]
13. Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules.
Dessein A; Samuelson JC; Butterworth AE; Hogan M; Sherry BA; Vadas MA; David JR
Parasitology; 1981 Jun; 82(Pt 3):357-74. PubMed ID: 7243345
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma japonicum and S. mansoni cercariae: different effects of protein in medium, of mechanical stress, and of an intact complement system on in vitro transformation to schistosomula.
Wang W; Kirschfink M; Ruppel A
Parasitol Res; 2006 Aug; 99(3):269-74. PubMed ID: 16547731
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni: killing of transformed schistosomula by the alternative pathway of human complement.
Marikovsky M; Levi-Schaffer F; Arnon R; Fishelson Z
Exp Parasitol; 1986 Feb; 61(1):86-94. PubMed ID: 3943595
[TBL] [Abstract][Full Text] [Related]
16. Host-Specific Serum Factors Control the Development and Survival of
Anisuzzaman ; Frahm S; Prodjinotho UF; Bhattacharjee S; Verschoor A; Prazeres da Costa C
Front Immunol; 2021; 12():635622. PubMed ID: 33968028
[TBL] [Abstract][Full Text] [Related]
17. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. I. Evidence that the loss in susceptibility to immune damage undergone by developing schistosomula involves a change unrelated to the masking of parasite antigens by host molecules.
Moser G; Wassom DL; Sher A
J Exp Med; 1980 Jul; 152(1):41-53. PubMed ID: 7400756
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human low density lipoprotein binding proteins on the surface of schistosomula of Schistosoma mansoni.
Xu X; Caulfield JP
Eur J Cell Biol; 1992 Apr; 57(2):229-35. PubMed ID: 1324838
[TBL] [Abstract][Full Text] [Related]
19. New insights into the reaction of Schistosoma mansoni cercaria to the human complement system.
Da'dara AA; Krautz-Peterson G
Parasitol Res; 2014 Oct; 113(10):3685-96. PubMed ID: 25030119
[TBL] [Abstract][Full Text] [Related]
20. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
Deng J; Gold D; LoVerde PT; Fishelson Z
Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
